Jennison Associates’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-24,787
| Closed | -$1.18M | – | 732 |
|
|
2021
Q4 | $1.18M | Sell |
24,787
-431,043
| -95% | -$20.6M | ﹤0.01% | 596 |
|
|
2021
Q3 | $30.3M | Sell |
455,830
-298,030
| -40% | -$19.8M | 0.02% | 301 |
|
|
2021
Q2 | $58.8M | Sell |
753,860
-105,951
| -12% | -$8.27M | 0.04% | 194 |
|
|
2021
Q1 | $81.3M | Buy |
859,811
+27,215
| +3% | +$2.57M | 0.06% | 147 |
|
|
2020
Q4 | $101M | Buy |
832,596
+200,564
| +32% | +$24.4M | 0.07% | 107 |
|
|
2020
Q3 | $55.2M | Sell |
632,032
-2,472
| -0.4% | -$216K | 0.04% | 166 |
|
|
2020
Q2 | $41M | Buy |
634,504
+5,756
| +0.9% | +$372K | 0.04% | 197 |
|
|
2020
Q1 | $28.1M | Buy |
628,748
+83,298
| +15% | +$3.72M | 0.03% | 210 |
|
|
2019
Q4 | $34M | Buy |
545,450
+227,258
| +71% | +$14.2M | 0.03% | 236 |
|
|
2019
Q3 | $12M | Buy |
318,192
+81,274
| +34% | +$3.06M | 0.01% | 380 |
|
|
2019
Q2 | $9.64M | Buy |
+236,918
| New | +$9.64M | 0.01% | 432 |
|